Planned Solutions, Inc. Bio N Tech Se Transaction History
Planned Solutions, Inc.
- $231 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
362Shares Held
38.2MCall Options Held
2.49MPut Options Held
2.26M-
Baillie Gifford & CO8.22MShares$941 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$505 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$492 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$217 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$207 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...